Shenoi, Susan http://orcid.org/0000-0002-2495-594X
Horneff, Gerd
Aggarwal, Amita
Ravelli, Angelo http://orcid.org/0000-0001-9658-0385
Article History
Accepted: 5 January 2024
First Online: 6 February 2024
Competing interests
: S.S. declares that she has received consulting fees from Amgen, Novartis and Pfizer, all unrelated to this manuscript. G.H. declares that has he has received grants from MSD, Novartis, Pfizer, Roche and consulting and/or speaker’s fees from AbbVie, Boehringer, Celgene, Chugai, GSK, Janssen, MSD, Novartis, Pfizer, Roche, Sanofi and Sobi, all unrelated to this manuscript. A.R. declares that has he has received grants from Novartis and Pfizer and consulting and/or speaker’s fees from AbbVie, Alexion, Angelini, Galapagos, Novartis, Pfizer, Reckitt-Benkiser, Roche, BMS and SOBI, all unrelated to this manuscript. A.A. declares no competing interests.